1. $ONCY 5-6 randomized trial data + half dozen single arm trial data coming out in next 12 months

  2. $ONCY Ellis Martin Report with Oncolytics Biotech s Dr Brad Thompson, published Oct/06/15. Interview 16:34 https://www.youtube.com/watch?v=YItK36a-2yU&feature=youtu.be

  3. $ONCY This is going to pop ! good news will keep coming out. Don t ask me to elaborate, just saying.

  4. $ONCY http://finance.yahoo.com/news/oncolytics-biotech-inc-announces-completion-103000408.html?.tsrc=applewf

  5. $ONCY: New SEC Filing for ONCY: Form 6-K, No. 0001279569-15-001924 http://stocknewsflow.com/1129928_000127956915001924_0001279569-15-001924

  6. Oncolytics: News Release Dated October 6, 2015 http://www.conferencecalltranscripts.org/8/summary2/?id=2069066 $ONCY

  7. $ONCY can t hold a gain...

  8. $ONCY Looking at the charts, everytime it gets down in the 40 s it spikes up, lets hope!

  9. $ONCY Still long

  10. recurrent or metastatic castration resistant prostate cancer $ONCY

  11. Oncolytics Biotech Inc ($ONCY) announced that enrollment has been completed in its randomized Phase II study of Reolysin in patients with...

  12. $oncy red EOD

  13. $oncy $LNCO just follow wanda an evrythin gonna be olright

  14. $ONCY biggest issue here is volume. always lacking.

  15. $ONCY Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Prostate Cancer Study http://stocknewsnow.com/companynews/78497175/ONCY/101843

  16. $ONCY ..Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Prostate Cancer Study http://www.oncolyticsbiotech.com/news/press-release-details/2015/Oncolytics-Biotech-Inc-Announces-Completion-of-Enrollment-in-Randomized-Phase-II-Prostate-Cancer-Study/default.aspx

  17. $ONCY ... a long time ago somebody ask me to join th v2 board on yahoo ....please send me the link again .....Thank You ......


  19. Monday thought on $DMRC, $AMRN, $AKAO, $ONCY, $BIOC, $ARTH http://tradingmytwocents.com/2015/10/06/monday-thought-on-dmrc-amrn-akao-oncy-bioc-arth-2/

  20. $ONCY NCI-9603 is a U.S. National Cancer Institute sponsored single-arm, open-label study of intravenously administered REOLYSIN®. Promising

  21. $ONCY buyout is inevitable.

  22. $ONCY sold this pos

  23. $ONCY hmm not sure what is happening...

  24. $ONCY where are you @stockmoneynews?

  25. $ONCY pos ceo 💩💩